Large-for-gestational age is male-gender dependent in artificial frozen embryo transfers cycles: a cohort study of 1295 singleton live births.


Journal

Reproductive biomedicine online
ISSN: 1472-6491
Titre abrégé: Reprod Biomed Online
Pays: Netherlands
ID NLM: 101122473

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 23 07 2019
revised: 05 10 2019
accepted: 17 10 2019
pubmed: 23 12 2019
medline: 10 4 2021
entrez: 23 12 2019
Statut: ppublish

Résumé

What is the effect of frozen embryo transfer (FET) on infant birth weight outcomes and which variables predic large-for-gestational age (LGA) infants. In a large cohort study, the birth weight of 1295 singleton live births from blastocyst freeze-all-IVF treatments carried out between February 2015 and February 2017 at a single IVF centre were analysed. All embryo transfers were vitrified-warmed blastocyst transfers in artificial FET cycles, with patients having one (n = 864) or two (n = 431) blastocysts transferred. All live births were from ultrasound confirmed single fetal heart pregnancies. The mean gestational age at delivery was 38.2 (±1.7) weeks, with a 1.11 : 1 female to male ratio for infants delivered. The small and large-for-gestational age rates were 5.02 and 13.28%, with 81.7% of infants appropriate for gestational age. In a multiple logistic regression analysis, the independent variables selected in the model to predict having an LGA infant were maternal parity, infant gender and maternal body mass index (BMI). The risk for LGA at term was significantly higher for male infants when adjusting for maternal parity and BMI (2.8 OR 1.805 to 4.450; P < 0.001). The present study showed that fetal growth of artificial cycle FET pregnancies resulted in an 13.28% LGA infant rate that was mostly male gender dependent.

Identifiants

pubmed: 31864903
pii: S1472-6483(19)30786-2
doi: 10.1016/j.rbmo.2019.10.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-141

Informations de copyright

Copyright © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Auteurs

Kevin Coetzee (K)

Antalya IVF, Halide Edip Cd. No: 3, Kanal Mh. Antalya 07080, Turkey. Electronic address: kevincoetzee61@yahoo.co.nz.

Kemal Ozgur (K)

Antalya IVF, Halide Edip Cd. No: 3, Kanal Mh. Antalya 07080, Turkey.

Hasan Bulut (H)

Antalya IVF, Halide Edip Cd. No: 3, Kanal Mh. Antalya 07080, Turkey.

Murat Berkkanoglu (M)

Antalya IVF, Halide Edip Cd. No: 3, Kanal Mh. Antalya 07080, Turkey.

Peter Humaidan (P)

The Fertility Clinic, Skive Regional Hospital and Faculty of Health, Aarhus University, Resenvej 25, Skive 7800, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH